We are live on ! Find out more
BIAFW icon

bioAffinity Technologies

4 hedge funds and large institutions have $55.9K invested in bioAffinity Technologies in 2026 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 3 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

162% more capital inflows, than outflows

Capital inflows: $3.49K | Capital outflows: $1.33K

33% more funds holding

Funds holding: 3 → 4 (+1)

0.43% more ownership

Funds ownership: 7.81% → 8.24% (+0.43%)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 3

Holders
4
Holders Change
+1
Holders Change %
+33.33%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
3
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$3.49K

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$1.16K
2
UBS Group
UBS Group
Switzerland
-$140
3
Clear Street
Clear Street
New York
-$36

BIAFW Hedge Fund Activity: Q1 2026 in Review

4 of the 8,244 institutional investors tracked by Wall St. Rank reported a position in bioAffinity Technologies (BIAFW) for Q1 2026, worth a combined $55.9K — up 29% from $43.3K a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new BIAFW positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 3 trimmed.

The largest buyer was Susquehanna International Group, opening a new position worth an estimated $3.49K. The largest seller was Citadel Advisors, cutting an estimated $1.16K.

  • 4 institutional investors held bioAffinity Technologies (BIAFW) as of Q1 2026, up from 3 in Q4 2025.
  • Funds reported $55.9K of bioAffinity Technologies stock for Q1 2026, up 29% quarter-over-quarter.
  • 1 fund opened new bioAffinity Technologies positions in Q1 2026 and 0 closed out, a net change of +1 holder.
  • The largest bioAffinity Technologies buyer in Q1 2026 was Susquehanna International Group, an estimated $3.49K added.
  • The largest bioAffinity Technologies seller in Q1 2026 was Citadel Advisors, an estimated $1.16K sold.

Based on aggregated 13F filings for Q1 2026.